Researchers discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea. These substances trigger a self-destruction program, which also ...

Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).

TB cases rise globally. New vaccine trials offer hope. Learn about TB's impact, risks, and a Dr. Alemnew Dagnew's fight for a ...

The WHO reports that tuberculosis cases in children are rising globally. Experts say a rise in TB cases in Europe could mean ...

Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.

It’s been three months since a global tuberculosis (TB) drug shortage was first reported. Motherwell Community Health Centre in Gqeberha, Eastern Cape is only left with five boxes of Rifinah, a ...

The umbrella programme Data Driven Research to Eradicate TB (Dare2eraD TB) was launched in March 2022 and included setting up ...

In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory ...

Even if US foreign aid cuts are reversed, the damage to global TB control has already been done, says Saw Swee Hock School of ...

It has been 20 years since Walter Thomas, 60, was diagnosed with tuberculosis (TB). In all those years, he has been visiting the hospital weekly to be tested and get injections for multi-drug ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. Globally, an estimated 10.8 million people ...

Established in 1941, Sewri TB Hospital operates with a capacity of 1,000 beds, including 240 beds reserved for multi-drug resistant TB (MDR-TB) patients. With full occupancy year-round ...